Sierra Oncology (NASDAQ:SRRA)

Sierra Oncology (NASDAQ:SRRA)


Share Price
$ 0.55
Change
-0.0095 (-1.70 %)
Market Cap
$41.08 m
Proactive Investors - Run By Investors For Investors

Sierra Oncology

We are a clinical stage drug development company advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

EPIC: SRRA
Market: NASDAQ:SRRA
52-week High/Low: $3.000 / $0.533
Market Cap: $41.08 m
Website: www.sierraoncology.com
col 3
col 4
col 5
col 6

Sierra Oncology Timeline

Market Reports Including SRRA

VIEW ALL

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use